Reduced plasma taurine level in Parkinson's disease: association with motor severity and levodopa treatment
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
PURPOSE: This study aimed to evaluate the level of taurine in plasma, and its association with the severity of motor and non-motor symptoms (NMS) and chronic levodopa treatment in Parkinson's disease (PD). PATIENTS AND METHODS: Plasma taurine level was measured in treated PD (tPD), untreated PD (ntPD) and control groups. Motor symptoms and NMS were assessed using the Unified Parkinson's Disease Rating Scale, the short form of the McGill Pain Questionnaire, the Hamilton Depression Scale, the Scale for Outcomes in Parkinson's disease for Autonomic Symptoms and the Pittsburgh Sleep Quality Index. Longtime exposure to levodopa was indicated by its approximate cumulative dosage. RESULTS: The plasma taurine levels of PD patients were decreased when compared with controls and negatively associated with motor severity but not NMS. Moreover, tPD patients exhibited lower levels of plasma taurine than ntPD patients. Interestingly, plasma taurine levels negatively correlated with cumulative levodopa dosage in tPD. After controlling for potential confounders, the association between taurine and levodopa remained significant. CONCLUSION: Our study supports that taurine may play important roles in the pathophysiology of PD and the disturbances caused by chronic levodopa administration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1991) · Sleep · doi:10.1093/sleep/14.4.331 · Cited by 874 · cited 3×
“The two PD groups did not differ in age at onset, SF-MPQ scores, HAMD scores, SCOPA-AUT scores or PSQI scores.”
Method
Cited by
CpG and non-CpG methylation in epigenetic gene regulation and brain function
Jang, H., Shin, W., Lee, J., & Do, J. (2017) · Genes · doi:10.3390/genes8060148 · Cited by 427
“Global DNA methylation analysis in a number of patients with PD has revealed that multiple genes involved in neurogenesis, including Wnt, are more hypermethylated in PD brain than in normal brain [131].”
BackgroundEffects and Mechanisms of Taurine as a Therapeutic Agent
Schaffer, S., & Kim, H. W. (2018) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.251 · Cited by 414
Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson’s Disease
Li, Y., Xia, Y., Yin, S., Wan, F., Hu, J., Kou, L., Sun, Y., Wu, J., Zhou, Q., Huang, J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.719807 · Cited by 230
Diet and the gut microbiome in patients with Parkinson’s disease
Kwon, D., Zhang, K., Paul, K. C., Folle, A. D., Del Rosario, I., Jacobs, J. P., Keener, A. M., Bronstein, J. M., & Ritz, B. (2024) · npj Parkinson's Disease · doi:10.1038/s41531-024-00681-7 · Cited by 86
Self-citation
Metadata
- Authors
- Zhang, L., Yuan, Y., Tong, Q., Jiang, S., Xu, Q., Ding, J., Zhang, L., Zhang, R., & Zhang, K.
- Venue
- International Journal of Neuroscience
- Publisher
- Informa UK Limited
- Published
- 2015-05-23
- Volume
- 126
- Issue
- 7
- Pages
- 1-7
- ISSN
- 0020-7454 (ISSN-L)
- 1543-5245
- OpenAlex
- W1865350477
- Cited by
- 35
- References
- 1
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reduced plasma taurine level in Parkinson's disease: association with motor severity and levodopa treatment. https://app.cochat.ai/papers/10.3109/00207454.2015.1051046
- The paper
- Zhang, L., Yuan, Y., Tong, Q., Jiang, S., Xu, Q., Ding, J., Zhang, L., Zhang, R., & Zhang, K. (2015). Reduced plasma taurine level in Parkinson's disease: association with motor severity and levodopa treatment. International Journal of Neuroscience. https://doi.org/10.3109/00207454.2015.1051046
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.